Inventage Lab, Inc.

As of June 30, 2026, Inventage Lab, Inc. carries a market capitalization of 524.45B, placing it among publicly traded companies globally. Its enterprise value stands at 466.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Inventage Lab, Inc. has 13.28M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 198.95, and the price-to-book ratio stands at 5.94.

These figures are as of June 30, 2026. The EV/Sales ratio of 188.54 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 466.23B versus a market cap of 524.45B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Inventage Lab, Inc. maintains a current ratio of 2.86, meaning it holds 2.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 31.33, indicating elevated leverage, while an interest coverage ratio of -23.93 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Inventage Lab, Inc. posted a negative return on equity (ROE) of -4.84, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -2.02, reflecting losses generated across the asset base. The company generates approximately 34.34M in revenue per employee across its workforce of 72.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 5.83 indicates how many times Inventage Lab, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Inventage Lab, Inc. recorded 1.12B in income tax expense. The company reported a pretax loss of -9.64B and -3.14B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Inventage Lab, Inc.'s stock has declined approximately 41.33% over the past 52 weeks. The 50-day moving average sits at 27,219.00, while the 200-day moving average is 52,489.25.

Over the twelve months ended June 30, 2026, Inventage Lab, Inc. generated 2.47B in revenue and converted that into -3.14B in net income, yielding earnings per share of -864.39. EBITDA reached -25.67B, while operating income came in at -33.62B.

As of June 30, 2026, Inventage Lab, Inc. holds 115.75B in cash and equivalents against 34.80B in total debt, resulting in a net debt position of -68.67B. Total book value stands at 88.36B, with working capital of 78.88B providing operational flexibility.

Inventage Lab, Inc. produced -22.80B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -11.53B in capital expenditures, free cash flow totaled -34.33B - equivalent to -2,756.35 per share.

Over the twelve months ended June 30, 2026, Inventage Lab, Inc. posted a gross margin of -179.00, reflecting its pricing power and cost economics. The operating margin of -1,359.73 and net profit margin of -127.01 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -6.98: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -20.96, meaning Inventage Lab, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Inventage Lab, Inc. has an Altman Z-Score of 3.15, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.